Core trials

Trials in setup


Immune activation is strongly implicated in a number of neurodegenerative diseases, including Parkinson’s disease (PD) and related Parkinson-Plus disorders. Our own work has demonstrated not only that there is a genetic link between the immune…


At least one quarter of the adult UK population has hypertension, a major risk factor for heart attacks and stroke. Primary hyperaldosteronism (PHA), a treatable form of hypertension, accounts for 5-10% of all cases, and 20-25% of those with…


Information coming soon.


A substantial proportion of the world’s disease burden is caused by infectious agents that lead to high mortality, morbidity, and reduced productivity among many millions of people and their animals. Guided by the Millennium Development Goals (…


Information coming soon.


For patients with chronic diseases such as neurodegenerative disorders and immune-mediated inflammatory diseases, a key attribute for any successful therapeutic intervention is its ability to improve the patients’ activities of daily living (ADL…


Information coming soon.